Implant Loads: Why Quarantine and Biological Monitoring Matter

Implantable devices require a deliberate release process because an inadequately processed implant may remain in a patient and may be difficult to retrieve. CDC recommends using a biological indicator (BI) for every sterilizer load containing implantable items and, whenever possible, quarantining those items until the BI result is negative. CDC classifies this recommendation as Category IB, meaning it is a strong recommendation supported by certain clinical or epidemiological studies and a strong theoretical rationale; local requirements and validated procedures may be stricter.[1][3] WHO likewise recommends using a BI for every load containing an implantable device and quarantining the items until the BI results are available (WHO, Decontamination and reprocessing of medical devices for health-care facilities, chapter on sterilization, section “Monitoring of sterilization,” p. 77).[2]

Quarantine and BI testing are parts of a broader monitoring process. A negative BI is important, but it does not prove that every item in the load was exposed to adequate sterilization conditions. Release decisions should therefore consider the complete set of available process information, including the cycle record, chemical indicators, BI results, package condition, and load documentation.

Why implant loads require a distinct release process

Sterilization assurance uses complementary forms of information. Physical or mechanical records show whether the cycle recorded the programmed exposure conditions. Chemical indicators provide information about exposure to the sterilization process at the location of the indicator. A BI uses resistant spores to provide a biological challenge to the process and is not interchangeable with a chemical indicator.[1]

These tools answer different questions. A cycle record may show that programmed process parameters were recorded. A chemical indicator may show the expected response at a package or test-system location. A BI result provides information about the ability of the tested process to inactivate the indicator organism under the conditions of the test. None of these results should be treated as a substitute for the others, and a negative BI alone does not establish that every item in a load was properly processed.

Core controls for an implant-containing load

1. Identify the load before sterilization

The load record should clearly identify that an implantable device is present. CDC recommendations include recording the sterilizer and cycle, load identification number, load contents, exposure parameters, operator identification, and mechanical, chemical, and biological monitoring results.[3]

As a facility-level implementation example, the tracking record may link the sterilizer, cycle, load number, implant or package identifier, exposure record, operator, BI result, and release decision. These links help staff apply the intended release process before the load is stored, transferred, or made available for a procedure. The exact fields and approval workflow should follow the facility’s validated process and applicable instructions for use.

2. Use a BI appropriate for the process

The BI should be appropriate for the sterilization method and cycle and used according to the BI manufacturer’s instructions. Its placement should provide a meaningful challenge to the process while accounting for the test device, load arrangement, and sterilizer manufacturer’s instructions. CDC describes BI monitoring as process-specific and recommends BI monitoring for every load containing implantable objects.[1]

A positive control should be used when required by the BI manufacturer’s instructions. The control helps determine whether the BI lot and incubation or readout system were capable of producing the expected result. WHO also describes use of a control according to the BI manufacturer’s instructions as part of the monitoring process (chapter on sterilization, section “Monitoring of sterilization,” p. 77).[2]

3. Quarantine the implant until the BI result is available

The preferred routine workflow is to segregate the implant-containing load and prevent its use until the BI result is negative. CDC states that implantable items should be quarantined whenever possible until the spore test is negative.[1] WHO supports BI use for every load containing an implantable device and quarantine until the BI results are available (chapter on sterilization, section “Monitoring of sterilization,” p. 77).[2]

Quarantine controls are facility-level implementation measures. Depending on the local workflow, they may include:

• a designated physical holding area or electronic hold status;
• a label identifying the implant load and its release status;
• a named role responsible for reviewing the BI result;
• a release record linking the BI result to the specific load; and
• a defined escalation route for a positive, invalid, delayed, or uninterpretable result.

These examples are not a universal format or additional external requirement. The facility should define ownership, documentation, and escalation in its validated procedures.

What should be reviewed before release?

Before releasing an implant-containing load, the responsible reviewer should evaluate the available evidence and confirm that the load meets the facility’s release procedure. A review may include:

• the selected sterilizer and cycle;
• the cycle record and recorded exposure conditions, assessed against the validated process and equipment instructions;
• the BI type, placement, processing, and readout;
• the validity of the required positive control and readout system;
• the expected response of chemical indicators;
• package integrity and, where applicable, dryness, with no visible contamination or damage; and
• agreement among the load number, package label, monitoring records, and implant documentation.

Package condition, record linkage, and reviewer sign-off are facility-level release controls unless otherwise specified by applicable instructions or local procedure. They are important because a negative BI cannot correct an incorrect cycle selection, a compromised package, a documentation mismatch, or failure to follow the device manufacturer’s reprocessing instructions. The reviewer should also confirm that no unresolved monitoring or equipment concern places the load on hold.

Managing a positive or invalid BI result

A positive or invalid BI associated with an implant-containing load should result in a hold while the facility follows its investigation and escalation procedure. The affected implant should not be released while the result is unresolved.

CDC Table 12 is a suggested protocol for managing a positive BI in a steam sterilizer. It includes taking the sterilizer out of service, notifying responsible supervisory and infection-prevention personnel, reviewing the sterilization procedure, and repeating BI testing in consecutive cycles.[4] Table 12 does not establish a universal implant-load release policy, recall threshold, or recall process. Its steam-specific protocol should not be generalized automatically to other sterilization methods. For non-steam processes, the facility should follow the applicable method-specific instructions, validated procedures, and manufacturer guidance.

The investigation should be assigned to defined facility roles and may consider the cycle, load configuration, BI placement and handling, chemical-indicator results, physical or electronic records, control results, and relevant equipment or utility concerns. The investigation outcome should determine whether the load remains quarantined, is reprocessed, or may be released under the facility’s documented procedure.[1][4]

For a focused discussion of investigation and response, see KrinMed’s Positive Biological Indicator article. For documentation and traceability controls, see Sterilization Traceability.

Emergency release should not become routine

Clinical urgency may create pressure to release an implant before the BI result is available. Any such decision must follow the facility’s written policy, authorization process, and documented risk assessment. The decision should involve the roles designated by the facility, which may include sterile processing, infection prevention, the procedural team, and risk management. An emergency does not remove the need to document the decision or address an abnormal monitoring result.

Long-term process improvements can reduce avoidable delays. Facility-level examples include defining expected BI turnaround times, maintaining adequate inventory where feasible, identifying implant loads prominently, and displaying quarantine status in the tracking system.

Practical audit questions

During an internal review, ask:

• Can staff identify every load containing an implantable device?
• Is a BI used for every implant-containing load?
• Are implant loads physically or electronically quarantined until the BI result is negative, whenever possible?
• Does the release record link the BI, required control, cycle record, and load number?
• Are positive, invalid, or delayed results managed through a defined escalation process?
• Can the facility reconstruct which implant was processed in which load?
• Does the release review assess the complete record rather than relying on the BI result alone?

Limitations

Monitoring guidance may vary by jurisdiction, sterilization method, device type, facility policy, and manufacturer instructions. This article does not replace the sterilizer, BI, process challenge device, packaging, implant, or instrument manufacturer’s instructions for use. It does not establish a universal emergency-release policy, recall threshold, or release format. Organizations should reconcile their procedures with applicable requirements, validated processes, and local infection-prevention policies.

Educational disclaimer: This article is for professional education and quality-improvement purposes. It is not patient-specific medical advice and does not replace clinical judgment, applicable requirements, or manufacturer instructions.

References

1. Sterilizing Practices. Centers for Disease Control and Prevention. 2023-11-28.
2. Decontamination and reprocessing of medical devices for health-care facilities. World Health Organization. 2024.
3. Summary of Recommendations: Sterilization. Centers for Disease Control and Prevention. 2023-11-28.
4. Table 12: Suggested protocol for management of positive biological indicator in a steam sterilizer. Centers for Disease Control and Prevention. 2023-12-20.

Educational overview. Follow the applicable product instructions, validated procedures, local regulations and your facility’s approved policies.